Abstract
Based on worldwide consultations with experts in science and ethics the revised CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects provide guidance on when the use of placebo as a comparator in clinical research is ethically acceptable. The article reviews the main points of the CIOMS Guidelines and commentaries including the use of placebo in situations where the best current method is available and the relation of placebo to established effective intervention. It discusses the use of placebo in externally sponsored research in low-resource countries and requirements for informed consent related to placebo studies.
Similar content being viewed by others
References
CIOMS (2002) International Ethical Guidelines for Biomedical Research Involving Human Subjects, CIOMS, Geneva. ISBN 92 9036 075 5. Available on the Internet: www.cioms.ch
Temple, R. & Ellenberg S.S. (2000) Placebo-controlled trials and active control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Ann Int Med 133: 455–463.
Idänpään-Heikkilä JE (2001) Ethical principles for the guidance of physicians in medical research- the Declaration of Helsinki. Bull WHO 79: 279.
Emanuel E.J. & Miller F.G.: The ethics of placebo-controlled trials — A middle Ground. NEJM 345: 915–919.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Idänpään-Heikkilä, J.E., Fluss, S. The CIOMS view on the use of placebo in clinical trials. SCI ENG ETHICS 10, 23–28 (2004). https://doi.org/10.1007/s11948-004-0058-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11948-004-0058-9